Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Sell rating on Sarepta Therapeutics (SRPT – Research Report). The associated ...

Gary Young, the PGA Tour’s senior vice president of rules and competition, said players and fans have suggested they could ...

PepGen (PEPG) “provided recent updates on its CONNECT clinical program investigating PGN-EDO51 in Duchenne muscular dystrophy for patients ...

El Paso Electric is using an integrated data access solution from Oracle and UtilityAPI that is intended to meet the Green ...

The gene therapy delandistrogene moxeparvovec-rokl showed clinically meaningful benefits and disease stabilization at 2 years ...

The positive results from the second part of the EMBARK trial contrast with findings from one-year post treatment, which did ...

Sculpture Walter Gazari on why artist bios are irrelevant and the pursuit of bringing what is in his mind's eye to life.

Roche has reported positive topline outcomes from the second year of the multinational Phase III EMBARK trial of Elevidys ...

Sarepta Therapeutics unveiled new results from the second part of a clinical trial for its Duchenne muscular dystrophy gene ...

El Paso Electric is using an integrated data access solution from Oracle and UtilityAPI that meets the Green Button Download My Data (DMD) and Connect My Data (CMD) certification requirements. The ...

Roche on Monday revealed positive results from the EMBARK trial, showing that its gene therapy Elevidys has sustained ...

Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and ...